DARPA - Biological Technologies Office

Description

DARPA seeks novel approaches to reversibly pause and/or slow the functions and preserve viability of living cells without reliance on cold temperature. This new technology aims to directly address needs within the Department of Defense to maintain and deliver biological therapeutics and extend the window of time for effective use of field forward therapeutics. See the HR001118S0034 document attached.

Who can apply

• Unrestricted

Contact

DARPA/BTO <br/>ATTN: HR001118S0034 <br/>675 North Randolph Street <br/>Arlington, VA 22203-2114
Biostasis@darpa.mil